Profile | GDS5420 / 208499_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 575.99 | 70 |
GSM1296119 | B_lesional_pre-dose | 514.16 | 68 |
GSM1296076 | C_lesional_pre-dose | 456.5 | 67 |
GSM1296092 | D_lesional_pre-dose | 439.01 | 66 |
GSM1296103 | E_lesional_pre-dose | 761.99 | 75 |
GSM1296078 | F_lesional_pre-dose | 429.44 | 66 |
GSM1296107 | G_lesional_pre-dose | 608.29 | 71 |
GSM1296109 | H_lesional_pre-dose | 1028.46 | 80 |
GSM1296080 | I_lesional_pre-dose | 302.09 | 60 |
GSM1296090 | J_lesional_pre-dose | 429.08 | 66 |
GSM1296074 | K_lesional_pre-dose | 585.72 | 71 |
GSM1296111 | L_lesional_pre-dose | 617.38 | 71 |
GSM1296099 | M_lesional_pre-dose | 534.6 | 69 |
GSM1296086 | O_lesional_pre-dose | 441.31 | 66 |
GSM1296117 | P_lesional_pre-dose | 635.18 | 72 |
GSM1296113 | Q_lesional_pre-dose | 649.2 | 72 |
GSM1296096 | R_lesional_pre-dose | 746.68 | 74 |
GSM1296105 | S_lesional_pre-dose | 370.61 | 62 |
GSM1296098 | T_lesional_pre-dose | 498.74 | 67 |
GSM1296101 | U_lesional_pre-dose | 558.61 | 69 |
GSM1296121 | V_lesional_pre-dose | 674.01 | 73 |
GSM1296088 | W_lesional_pre-dose | 530.93 | 69 |
GSM1296082 | X_lesional_pre-dose | 496.72 | 68 |
GSM1296115 | Y_lesional_pre-dose | 787.23 | 75 |
GSM1296084 | Z_lesional_pre-dose | 284 | 58 |
GSM1296072 | B_lesional_day8 | 329.61 | 60 |
GSM1296069 | L_lesional_day8 | 806 | 76 |
GSM1296071 | P_lesional_day8 | 564.21 | 69 |
GSM1296070 | Y_lesional_day8 | 563.65 | 69 |
GSM1296073 | V_lesional_day8 | 617.39 | 72 |
GSM1296034 | A_lesional_day15 | 323.65 | 59 |
GSM1296041 | G_lesional_day15 | 545.5 | 69 |
GSM1296035 | R_lesional_day15 | 636.88 | 71 |
GSM1296038 | U_lesional_day15 | 557.59 | 70 |
GSM1296047 | B_lesional_day15 | 447.04 | 66 |
GSM1296039 | E_lesional_day15 | 394.97 | 64 |
GSM1296042 | H_lesional_day15 | 507.77 | 68 |
GSM1296043 | L_lesional_day15 | 554.97 | 69 |
GSM1296037 | M_lesional_day15 | 327.66 | 60 |
GSM1296046 | P_lesional_day15 | 549.34 | 69 |
GSM1296044 | Q_lesional_day15 | 522.9 | 68 |
GSM1296045 | Y_lesional_day15 | 536.84 | 69 |
GSM1296025 | C_lesional_day15 | 306.21 | 60 |
GSM1296033 | D_lesional_day15 | 257.84 | 57 |
GSM1296027 | I_lesional_day15 | 206.91 | 54 |
GSM1296032 | J_lesional_day15 | 259.73 | 56 |
GSM1296024 | K_lesional_day15 | 322.62 | 61 |
GSM1296031 | W_lesional_day15 | 341.26 | 60 |
GSM1296028 | X_lesional_day15 | 262.76 | 57 |
GSM1296029 | Z_lesional_day15 | 234.47 | 55 |
GSM1296026 | F_lesional_day15 | 414.94 | 65 |
GSM1296030 | O_lesional_day15 | 258.7 | 58 |
GSM1296040 | S_lesional_day15 | 573.38 | 70 |
GSM1296036 | T_lesional_day15 | 388.78 | 63 |
GSM1296048 | V_lesional_day15 | 557.53 | 70 |
GSM1296059 | A_lesional_day43 | 692.48 | 73 |
GSM1296066 | G_lesional_day43 | 562.02 | 70 |
GSM1296060 | R_lesional_day43 | 473.13 | 67 |
GSM1296063 | U_lesional_day43 | 409.12 | 65 |
GSM1296064 | E_lesional_day43 | 621.44 | 72 |
GSM1296067 | H_lesional_day43 | 475.42 | 66 |
GSM1296062 | M_lesional_day43 | 347.54 | 61 |
GSM1296068 | Q_lesional_day43 | 506.49 | 67 |
GSM1296050 | C_lesional_day43 | 393.86 | 64 |
GSM1296057 | D_lesional_day43 | 304.78 | 59 |
GSM1296052 | I_lesional_day43 | 229.82 | 56 |
GSM1296054 | J_lesional_day43 | 254.15 | 55 |
GSM1296049 | K_lesional_day43 | 291.28 | 59 |
GSM1296055 | W_lesional_day43 | 486.53 | 67 |
GSM1296053 | X_lesional_day43 | 285.27 | 58 |
GSM1296058 | Z_lesional_day43 | 334.97 | 61 |
GSM1296051 | F_lesional_day43 | 455.47 | 67 |
GSM1296056 | O_lesional_day43 | 514.93 | 69 |
GSM1296065 | S_lesional_day43 | 358.08 | 62 |
GSM1296061 | T_lesional_day43 | 372.48 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 415.15 | 65 |
GSM1296120 | B_non-lesional_pre-dose | 480.34 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 325.63 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 384.4 | 62 |
GSM1296104 | E_non-lesional_pre-dose | 393.83 | 64 |
GSM1296079 | F_non-lesional_pre-dose | 323.46 | 61 |
GSM1296108 | G_non-lesional_pre-dose | 485.65 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 615.71 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 312.15 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 224.93 | 55 |
GSM1296075 | K_non-lesional_pre-dose | 360.29 | 63 |
GSM1296112 | L_non-lesional_pre-dose | 549.4 | 69 |
GSM1296100 | M_non-lesional_pre-dose | 365.21 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 156.59 | 50 |
GSM1296118 | P_non-lesional_pre-dose | 615.14 | 71 |
GSM1296114 | Q_non-lesional_pre-dose | 591.95 | 70 |
GSM1296097 | R_non-lesional_pre-dose | 463.53 | 67 |
GSM1296106 | S_non-lesional_pre-dose | 408.11 | 64 |
GSM1296102 | U_non-lesional_pre-dose | 322.49 | 59 |
GSM1296122 | V_non-lesional_pre-dose | 509.58 | 68 |
GSM1296089 | W_non-lesional_pre-dose | 360.61 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 373.62 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 594.31 | 70 |
GSM1296085 | Z_non-lesional_pre-dose | 240.79 | 55 |